This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma
BMC Cancer Open Access 23 April 2008
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lok ASF, Liang RHS, Chiu EKW, Wong KL, Chan TK, Todd D . Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy Gastroenterology 1991 100: 182–188
Czuczman MS, Grillo-Lopez AJ, White CA, Saleh M, Gordon L, Lobuglio AF, Jonas C, Klippenstein D, Dallaire B, Varns C . Treatment of patients with low grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy J Clin Oncol 1999 17: 268–276
Dervite I, Hober D, Morel P . Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab N Engl J Med 2001 344: 68–69
Ng HJ, Lim LC . Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report Ann Hematol 2001 80: 549–552
Dai MS, Lu JJ, Chen YC, Perng CL, Chao TY . Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients Cancer 2001 92: 2927–2932
Marusawa H, Imoto S, Ueda Y, Chiba T . Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen J Gastroenterol 2001 36: 633–636
Hamaki T, Kami M, Kusumi E, Ueyama J, Miyakoshi S, Morinaga S, Mutou Y . Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab Am J Hematol 2001 68: 291–294
Wasif-Saif M, Little RF, Hamilton JM, Allegra CJ, Wilson WH . Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case report and review of literature Ann Oncol 2001 12: 123–129
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Skrabs, C., Müller, C., Agis, H. et al. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge. Leukemia 16, 1884–1886 (2002). https://doi.org/10.1038/sj.leu.2402567
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402567
This article is cited by
-
Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention
Rheumatology International (2016)
-
Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia
International Journal of Hematology (2015)
-
Screening and Vaccinations in Patients Requiring Systemic Immunosuppression: An Update for Dermatologists
American Journal of Clinical Dermatology (2015)
-
Retrospective analysis of hepatitis B virus reactivation after rituximab combination chemotherapy in patients with B-cell lymphoma
The Chinese-German Journal of Clinical Oncology (2011)
-
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients
Annals of Hematology (2010)